Marcus Corporation - 10-Q quarterly report FY2023 Q2

000006223412-282023Q2false0.09080380.091963100000622342022-12-302023-06-290000062234us-gaap:CommonStockMember2023-07-31xbrli:shares0000062234us-gaap:CommonClassBMember2023-07-3100000622342023-06-29iso4217:USD00000622342022-12-29iso4217:USDxbrli:shares0000062234us-gaap:CommonStockMember2023-06-290000062234us-gaap:CommonStockMember2022-12-290000062234us-gaap:CommonClassBMember2022-12-290000062234us-gaap:CommonClassBMember2023-06-290000062234us-gaap:AdmissionMember2023-03-312023-06-290000062234us-gaap:AdmissionMember2022-04-012022-06-300000062234us-gaap:AdmissionMember2022-12-302023-06-290000062234us-gaap:AdmissionMember2021-12-312022-06-300000062234us-gaap:OccupancyMember2023-03-312023-06-290000062234us-gaap:OccupancyMember2022-04-012022-06-300000062234us-gaap:OccupancyMember2022-12-302023-06-290000062234us-gaap:OccupancyMember2021-12-312022-06-300000062234us-gaap:ConcessionsMember2023-03-312023-06-290000062234us-gaap:ConcessionsMember2022-04-012022-06-300000062234us-gaap:ConcessionsMember2022-12-302023-06-290000062234us-gaap:ConcessionsMember2021-12-312022-06-300000062234us-gaap:FoodAndBeverageMember2023-03-312023-06-290000062234us-gaap:FoodAndBeverageMember2022-04-012022-06-300000062234us-gaap:FoodAndBeverageMember2022-12-302023-06-290000062234us-gaap:FoodAndBeverageMember2021-12-312022-06-300000062234us-gaap:ProductAndServiceOtherMember2023-03-312023-06-290000062234us-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000062234us-gaap:ProductAndServiceOtherMember2022-12-302023-06-290000062234us-gaap:ProductAndServiceOtherMember2021-12-312022-06-3000000622342023-03-312023-06-2900000622342022-04-012022-06-3000000622342021-12-312022-06-300000062234mcs:TheatreOperationsMember2023-03-312023-06-290000062234mcs:TheatreOperationsMember2022-04-012022-06-300000062234mcs:TheatreOperationsMember2022-12-302023-06-290000062234mcs:TheatreOperationsMember2021-12-312022-06-300000062234us-gaap:CommonStockMember2023-03-312023-06-290000062234us-gaap:CommonStockMember2022-04-012022-06-300000062234us-gaap:CommonStockMember2022-12-302023-06-290000062234us-gaap:CommonStockMember2021-12-312022-06-300000062234us-gaap:CommonClassBMember2023-03-312023-06-290000062234us-gaap:CommonClassBMember2022-04-012022-06-300000062234us-gaap:CommonClassBMember2022-12-302023-06-290000062234us-gaap:CommonClassBMember2021-12-312022-06-3000000622342021-12-3000000622342022-06-30xbrli:pure0000062234us-gaap:CommonStockMember2021-12-312022-06-300000062234mcs:SharesRelatedToConvertibleNotesMember2022-12-302023-06-290000062234mcs:SharesRelatedToConvertibleNotesMember2021-12-312022-06-300000062234us-gaap:CommonStockMember2022-12-290000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-290000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-12-290000062234us-gaap:RetainedEarningsMember2022-12-290000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-290000062234us-gaap:TreasuryStockCommonMember2022-12-290000062234us-gaap:ParentMember2022-12-290000062234us-gaap:NoncontrollingInterestMember2022-12-290000062234us-gaap:CommonClassBMember2022-12-302023-03-300000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2022-12-302023-03-300000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2022-12-302023-03-300000062234us-gaap:CommonStockMember2022-12-302023-03-300000062234us-gaap:RetainedEarningsMember2022-12-302023-03-300000062234us-gaap:ParentMember2022-12-302023-03-3000000622342022-12-302023-03-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-12-302023-03-300000062234us-gaap:TreasuryStockCommonMember2022-12-302023-03-300000062234us-gaap:CommonStockMember2022-12-302023-03-300000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-302023-03-300000062234us-gaap:NoncontrollingInterestMember2022-12-302023-03-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-302023-03-300000062234us-gaap:CommonStockMember2023-03-300000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-03-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-03-300000062234us-gaap:RetainedEarningsMember2023-03-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-300000062234us-gaap:TreasuryStockCommonMember2023-03-300000062234us-gaap:ParentMember2023-03-300000062234us-gaap:NoncontrollingInterestMember2023-03-3000000622342023-03-300000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2023-03-312023-06-290000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2023-03-312023-06-290000062234us-gaap:RetainedEarningsMember2023-03-312023-06-290000062234us-gaap:ParentMember2023-03-312023-06-290000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-03-312023-06-290000062234us-gaap:TreasuryStockCommonMember2023-03-312023-06-290000062234us-gaap:CommonStockMember2023-03-312023-06-290000062234us-gaap:NoncontrollingInterestMember2023-03-312023-06-290000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-312023-06-290000062234us-gaap:CommonStockMember2023-06-290000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-06-290000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-06-290000062234us-gaap:RetainedEarningsMember2023-06-290000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-290000062234us-gaap:TreasuryStockCommonMember2023-06-290000062234us-gaap:ParentMember2023-06-290000062234us-gaap:NoncontrollingInterestMember2023-06-290000062234us-gaap:CommonStockMember2021-12-300000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-12-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-12-300000062234us-gaap:RetainedEarningsMember2021-12-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-300000062234us-gaap:TreasuryStockCommonMember2021-12-300000062234us-gaap:ParentMember2021-12-300000062234us-gaap:NoncontrollingInterestMember2021-12-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-12-312022-03-310000062234us-gaap:TreasuryStockCommonMember2021-12-312022-03-310000062234us-gaap:ParentMember2021-12-312022-03-3100000622342021-12-312022-03-310000062234us-gaap:CommonStockMember2021-12-312022-03-310000062234us-gaap:RetainedEarningsMember2021-12-312022-03-310000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-12-312022-03-310000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-312022-03-310000062234us-gaap:NoncontrollingInterestMember2021-12-312022-03-310000062234us-gaap:CommonStockMember2022-03-310000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-03-310000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-03-310000062234us-gaap:RetainedEarningsMember2022-03-310000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000062234us-gaap:TreasuryStockCommonMember2022-03-310000062234us-gaap:ParentMember2022-03-310000062234us-gaap:NoncontrollingInterestMember2022-03-3100000622342022-03-310000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-04-012022-06-300000062234us-gaap:TreasuryStockCommonMember2022-04-012022-06-300000062234us-gaap:ParentMember2022-04-012022-06-300000062234us-gaap:CommonStockMember2022-04-012022-06-300000062234us-gaap:RetainedEarningsMember2022-04-012022-06-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000062234us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000062234us-gaap:CommonStockMember2022-06-300000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-06-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-06-300000062234us-gaap:RetainedEarningsMember2022-06-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000062234us-gaap:TreasuryStockCommonMember2022-06-300000062234us-gaap:ParentMember2022-06-300000062234us-gaap:NoncontrollingInterestMember2022-06-300000062234us-gaap:FairValueInputsLevel1Member2023-06-290000062234us-gaap:FairValueInputsLevel1Member2022-12-290000062234us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2023-06-290000062234us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-12-290000062234us-gaap:FairValueInputsLevel2Member2022-12-290000062234us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-290000062234us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-06-290000062234us-gaap:FairValueInputsLevel2Member2023-06-290000062234us-gaap:FairValueInputsLevel2Memberus-gaap:ConvertibleDebtMember2023-06-290000062234us-gaap:AdmissionMembermcs:TheatresSegmentMember2023-03-312023-06-290000062234mcs:HotelsOrResortsMemberus-gaap:OccupancyMember2023-03-312023-06-290000062234us-gaap:ConcessionsMembermcs:TheatresSegmentMember2023-03-312023-06-290000062234us-gaap:FoodAndBeverageMembermcs:HotelsOrResortsMember2023-03-312023-06-290000062234us-gaap:ProductAndServiceOtherMembermcs:TheatresSegmentMember2023-03-312023-06-290000062234mcs:HotelsOrResortsMemberus-gaap:ProductAndServiceOtherMember2023-03-312023-06-290000062234us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateMember2023-03-312023-06-290000062234mcs:TheatresSegmentMember2023-03-312023-06-290000062234mcs:HotelsOrResortsMember2023-03-312023-06-290000062234us-gaap:CorporateMember2023-03-312023-06-290000062234us-gaap:AdmissionMembermcs:TheatresSegmentMember2022-12-302023-06-290000062234mcs:HotelsOrResortsMemberus-gaap:OccupancyMember2022-12-302023-06-290000062234us-gaap:ConcessionsMembermcs:TheatresSegmentMember2022-12-302023-06-290000062234us-gaap:FoodAndBeverageMembermcs:HotelsOrResortsMember2022-12-302023-06-290000062234us-gaap:ProductAndServiceOtherMembermcs:TheatresSegmentMember2022-12-302023-06-290000062234mcs:HotelsOrResortsMemberus-gaap:ProductAndServiceOtherMember2022-12-302023-06-290000062234us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateMember2022-12-302023-06-290000062234mcs:TheatresSegmentMember2022-12-302023-06-290000062234mcs:HotelsOrResortsMember2022-12-302023-06-290000062234us-gaap:CorporateMember2022-12-302023-06-290000062234us-gaap:AdmissionMembermcs:TheatresSegmentMember2022-04-012022-06-300000062234mcs:HotelsOrResortsMemberus-gaap:OccupancyMember2022-04-012022-06-300000062234us-gaap:ConcessionsMembermcs:TheatresSegmentMember2022-04-012022-06-300000062234us-gaap:FoodAndBeverageMembermcs:HotelsOrResortsMember2022-04-012022-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:TheatresSegmentMember2022-04-012022-06-300000062234mcs:HotelsOrResortsMemberus-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000062234us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateMember2022-04-012022-06-300000062234mcs:TheatresSegmentMember2022-04-012022-06-300000062234mcs:HotelsOrResortsMember2022-04-012022-06-300000062234us-gaap:CorporateMember2022-04-012022-06-300000062234us-gaap:AdmissionMembermcs:TheatresSegmentMember2021-12-312022-06-300000062234mcs:HotelsOrResortsMemberus-gaap:OccupancyMember2021-12-312022-06-300000062234us-gaap:ConcessionsMembermcs:TheatresSegmentMember2021-12-312022-06-300000062234us-gaap:FoodAndBeverageMembermcs:HotelsOrResortsMember2021-12-312022-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:TheatresSegmentMember2021-12-312022-06-300000062234mcs:HotelsOrResortsMemberus-gaap:ProductAndServiceOtherMember2021-12-312022-06-300000062234us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateMember2021-12-312022-06-300000062234mcs:TheatresSegmentMember2021-12-312022-06-300000062234mcs:HotelsOrResortsMember2021-12-312022-06-300000062234us-gaap:CorporateMember2021-12-312022-06-300000062234mcs:AdvancedSaleOfTicketsMember2023-06-290000062234mcs:TheatresSegmentMember2023-06-290000062234mcs:AdvancedSaleOfTicketsMember2022-12-302023-06-290000062234mcs:CreditAgreementMember2023-06-290000062234us-gaap:RevolvingCreditFacilityMembermcs:SecuredOvernightFinancingRateSOFRMember2023-06-290000062234us-gaap:RevolvingCreditFacilityMember2023-06-290000062234mcs:CreditAgreementMembermcs:SecuredOvernightFinancingRateSOFRMember2023-02-102023-02-100000062234mcs:CreditAgreementMembermcs:SecuredOvernightFinancingRateSOFRMember2023-02-100000062234mcs:CreditAgreementMember2023-02-102023-02-100000062234mcs:SubjectTo1FloorMembermcs:CreditAgreementMembermcs:SecuredOvernightFinancingRateSOFRMember2023-02-102023-02-100000062234mcs:CreditAgreementMember2023-02-100000062234mcs:CreditAgreementMembersrt:MinimumMember2023-02-102023-02-100000062234srt:MaximumMembermcs:CreditAgreementMember2023-02-102023-02-100000062234mcs:CreditAgreementMember2022-12-302023-06-290000062234mcs:NotePurchaseAgreementMembersrt:MinimumMember2023-06-290000062234mcs:NotePurchaseAgreementMembersrt:MaximumMember2023-06-290000062234srt:MaximumMembermcs:CreditAgreementMember2021-12-312022-12-290000062234mcs:NotePurchaseAgreementMember2023-06-290000062234mcs:NotePurchaseAgreementMember2022-12-29mcs:agreement0000062234us-gaap:ConvertibleDebtMember2020-09-170000062234us-gaap:ConvertibleDebtMember2020-09-220000062234us-gaap:ConvertibleDebtMember2022-12-302023-06-290000062234us-gaap:ConvertibleDebtMember2020-09-172020-09-170000062234us-gaap:ConvertibleDebtMember2023-06-290000062234srt:ScenarioForecastMember2021-04-012023-09-2800000622342020-09-1700000622342020-09-172020-09-170000062234us-gaap:ConvertibleDebtMember2023-06-292023-06-290000062234srt:MinimumMember2023-06-290000062234srt:MaximumMember2023-06-290000062234mcs:FinanceLeasedAssetsMember2023-06-290000062234mcs:FinanceLeasedAssetsMember2022-12-290000062234mcs:OperatingLeaseLiabilityNoncurrentMember2023-06-290000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2023-03-312023-06-290000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2023-03-312023-06-290000062234us-gaap:CorporateNonSegmentMember2023-03-312023-06-290000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2022-04-012022-06-300000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2022-04-012022-06-300000062234us-gaap:CorporateNonSegmentMember2022-04-012022-06-300000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2022-12-302023-06-290000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2022-12-302023-06-290000062234mcs:CorporateItemsMemberus-gaap:CorporateNonSegmentMember2022-12-302023-06-290000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2021-12-312022-06-300000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2021-12-312022-06-300000062234mcs:CorporateItemsMemberus-gaap:CorporateNonSegmentMember2021-12-312022-06-30

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


x			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 29, 2023


o			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 1-12604


THE MARCUS CORPORATION
(Exact name of registrant as specified in its charter)


Wisconsin						39-1139844
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

100 East Wisconsin Avenue, Suite 1900 Milwaukee ,Wisconsin						53202-4125
(Address of principal executive offices)						(Zip Code)

Registrant’s telephone number, including area code: (414) 905-1000

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	MCS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.

Yes

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check One).


Large accelerated filer	o	Accelerated filer	x
Non-accelerated filer	o	Smaller reporting company	o
		Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

COMMON STOCK OUTSTANDING AT JULY 31, 2023 – 24,611,944

CLASS B COMMON STOCK OUTSTANDING AT JULY 31, 2023 –7,078,410

Table of Contents

THE MARCUS CORPORATION

INDEX

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

THE MARCUS CORPORATION

Consolidated Balance Sheets

(in thousands, except share and per share data)


	June 29, 2023		December 29, 2022
ASSETS
Current assets:
Cash and cash equivalents	$	44,580	$	21,704
Restricted cash	4,274		2,802
Accounts receivable, net of reserves of $163 and $172, respectively	20,591		21,455


Assets held for sale	558		460
Other current assets	21,579		17,474
Total current assets	91,582		63,895

Property and equipment:
Land and improvements	131,229		132,285
Buildings and improvements	730,955		729,177
Leasehold improvements	167,873		167,516
Furniture, fixtures and equipment	397,710		386,197
Finance lease right-of-use assets	29,998		29,885
Construction in progress	5,461		10,305
Total property and equipment	1,463,226		1,455,365
Less accumulated depreciation and amortization	764,048		739,600
Net property and equipment	699,178		715,765

Operating lease right-of-use assets	187,275		194,965

Other assets:
Investments in joint ventures	1,865		2,067
Goodwill	74,996		75,015

Other	13,054		12,891
Total other assets	89,915		89,973
TOTAL ASSETS	$	1,067,950	$	1,064,598

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

Consolidated Balance Sheets

(in thousands, except share and per share data)


	June 29, 2023		December 29, 2022
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	40,636	$	32,187
Income taxes	361		—
Taxes other than income taxes	19,618		17,948
Accrued compensation	18,901		22,512
Other accrued liabilities	56,861		56,275
Current portion of finance lease obligations	2,538		2,488
Current portion of operating lease obligations	14,596		14,553
Current maturities of long-term debt	10,391		10,432
Total current liabilities	163,902		156,395

Finance lease obligations	13,899		15,014

Operating lease obligations	187,026		195,281

Long-term debt	169,784		170,005

Deferred income taxes	27,292		26,567

Other long-term obligations	44,605		44,415

Equity:
Shareholders’ equity attributable to The Marcus Corporation
Preferred Stock, $1 par; authorized 1,000,000 shares; none issued	—		—
Common Stock, $1 par; authorized 50,000,000 shares; issued 24,691,548 shares at June 29, 2023 and 24,498,243 shares at December 29, 2022	24,692		24,498
Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 7,078,410 shares at June 29, 2023 and 7,110,875 shares at December 29, 2022	7,078		7,111
Capital in excess of par	158,231		153,794
Retained earnings	275,157		274,254
Accumulated other comprehensive loss	(1,797)		(1,694)
	463,361		457,963
Less cost of Common Stock in treasury (90,888 shares at June 29, 2023 and 78,882 shares at December 29, 2022)	(1,919)		(1,866)
Total shareholders’ equity attributable to The Marcus Corporation	461,442		456,097
Noncontrolling interest	—		824
Total equity	461,442		456,921

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,067,950	$	1,064,598

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

Consolidated Statements of Earnings (Loss)

(in thousands, except per share data)


	13 Weeks Ended				26 Weeks Ended
	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022
Revenues:
Theatre admissions	$	68,987	$	63,087	$	116,622	$	101,504
Rooms	28,646		28,865		46,503		46,295
Theatre concessions	59,707		58,147		102,082		93,611
Food and beverage	18,573		19,014		33,766		33,525
Other revenues	21,428		21,192		41,116		39,999
	197,341		190,305		340,089		314,934
Cost reimbursements	9,666		8,250		19,194		15,863
Total revenues	207,007		198,555		359,283		330,797

Costs and expenses:
Theatre operations	66,905		61,737		117,974		106,165
Rooms	10,360		10,471		19,638		18,674
Theatre concessions	22,601		22,993		38,331		38,186
Food and beverage	14,451		15,035		28,019		27,175
Advertising and marketing	5,613		5,978		10,678		10,459
Administrative	19,466		17,627		39,317		36,708
Depreciation and amortization	15,994		16,752		31,870		33,983
Rent	6,594		6,578		13,087		12,828
Property taxes	4,532		4,980		9,289		9,725
Other operating expenses	10,015		9,261		20,064		18,935


Reimbursed costs	9,666		8,250		19,194		15,863
Total costs and expenses	186,197		179,662		347,461		328,701

Operating income	20,810		18,893		11,822		2,096

Other income (expense):
Investment income (loss)	359		(459)		619		(727)
Interest expense	(3,093)		(4,063)		(6,101)		(8,155)
Other income (expense)	(477)		(653)		(878)		(806)
Equity earnings (losses) from unconsolidated joint ventures	(31)		7		(202)		(134)
	(3,242)		(5,168)		(6,562)		(9,822)

Earnings (loss) before income taxes	17,568		13,725		5,260		(7,726)
Income tax expense (benefit)	4,102		4,765		1,260		(1,784)
Net earnings (loss)	$	13,466	$	8,960	$	4,000	$	(5,942)



Net earnings (loss) per share - basic:
Common Stock	$	0.43	$	0.29	$	0.13	$	(0.19)
Class B Common Stock	$	0.39	$	0.26	$	0.12	$	(0.18)

Net earnings (loss) per share - diluted:
Common Stock	$	0.35	$	0.24	$	0.13	$	(0.19)
Class B Common Stock	$	0.34	$	0.23	$	0.12	$	(0.18)

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)


	13 Weeks Ended				26 Weeks Ended
	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Net earnings (loss)	$	13,466	$	8,960	$	4,000	$	(5,942)
Other comprehensive income (loss), net of tax:
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax effect (benefit) of $(4), $67, $(9) and $134, respectively	(12)		190		(23)		380
Fair market value adjustment of interest rate swap, net of tax effect (benefit) of $0, $37, $(8) and $116, respectively	—		106		(22)		329
Reclassification adjustment on interest rate swap included in interest expense, net of tax effect (benefit) of $0, $31, $(20) and $72, respectively	—		88		(58)		206
Other comprehensive income (loss)	(12)		384		(103)		915
Comprehensive income (loss)	$	13,454	$	9,344	$	3,897	$	(5,027)

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

Consolidated Statements of Cash Flows

(in thousands)


	26 Weeks Ended
	June 29, 2023		June 30, 2022

OPERATING ACTIVITIES:
Net income (loss)	$	4,000	$	(5,942)
Adjustments to reconcile net loss to net cash provided by operating activities:
Losses on investments in joint ventures	202		134
(Gain) loss on disposition of property, equipment and other assets	777		(355)

Depreciation and amortization	31,870		33,983
Amortization of debt issuance costs	742		826
Share-based compensation	3,687		4,572
Deferred income taxes	780		(1,505)
Other long-term obligations	176		(49)
Contribution of the Company’s stock to savings and profit-sharing plan	1,259		956
Changes in operating assets and liabilities:
Accounts receivable	895		2,629
Government grants receivable	—		4,335
Other assets	(1,796)		(4,294)
Operating leases	(522)		(1,047)
Accounts payable	6,341		551
Income taxes	94		22,720
Taxes other than income taxes	1,670		(347)
Accrued compensation	(3,634)		(1,595)
Other accrued liabilities	785		(344)
Total adjustments	43,326		61,170
Net cash provided by operating activities	47,326		55,228

INVESTING ACTIVITIES:
Capital expenditures	(15,896)		(16,341)
Proceeds from disposals of property, equipment and other assets	46		4,821

Proceeds from sale of trading securities	17		—
Purchase of trading securities	(514)		—

Other investing activities	(295)		45
Net cash used in investing activities	(16,642)		(11,475)

FINANCING ACTIVITIES:
Debt transactions:
Proceeds from borrowings on revolving credit facility	38,000		22,000
Repayment of borrowings on revolving credit facility	(38,000)		(22,000)

Repayments on short-term borrowings	—		(820)
Principal payments on long-term debt	(763)		(851)

Debt issuance costs	(50)		—
Principal payments on finance lease obligations	(1,201)		(1,336)
Equity transactions:
Treasury stock transactions, except for stock options	(494)		(1,461)
Exercise of stock options	93		79
Dividends paid	(3,097)		—
Distributions to noncontrolling interest	(824)		—
Net cash used in financing activities	(6,336)		(4,389)
Net increase in cash, cash equivalents and restricted cash	24,348		39,364
Cash, cash equivalents and restricted cash at beginning of period	24,506		24,054
Cash, cash equivalents and restricted cash at end of period	$	48,854	$	63,418

Supplemental Information:
Interest paid, net of amounts capitalized	$	4,622	$	7,054
Income taxes refunded (paid), including interest earned	(386)		22,998
Change in accounts payable for additions to property, equipment and other assets	2,096		2,003

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and per share data)

1. General

Basis of Presentation - The unaudited consolidated financial statements for the 13 and 26 weeks ended June 29, 2023 and June 30, 2022 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at June 29, 2023, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 29, 2022.

Accounting Policies - Refer to the Company’s audited consolidated financial statements (including footnotes) for the fiscal year ended December 29, 2022, contained in the Company’s Annual Report on Form 10-K for such year, for a description of the Company’s accounting policies.

Noncontrolling Interest - The Company has an ownership interest greater than 50% in one joint venture that is considered a Variable Interest Entity (VIE) that is included in the accounts of the Company. The Company is the primary beneficiary of the VIE and the Company’s interest is considered a majority voting interest. The primary asset of this VIE, The Skirvin Hilton, was sold on December 16, 2022. The equity interest of outside owners in consolidated entities is recorded as noncontrolling interest in the consolidated balance sheets.

Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $15,986 and $31,854 for the 13 and 26 weeks ended June 29, 2023, respectively, and $16,744 and $33,967 for the 13 and 26 weeks ended June 30, 2022, respectively.

Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset. As of June 29, 2023, assets held for sale consists of excess land.

Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value. There were no indicators of impairment identified during the 26 weeks ended June 29, 2023 or June 30, 2022.

Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 26 weeks ended June 29, 2023 or June 30, 2022.

Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.

Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.

The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share and provides a reconciliation of the number of weighted-average basic and diluted shares outstanding:


	13 Weeks Ended				26 Weeks Ended
	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Numerator:
Net earnings (loss)	$	13,466	$	8,960	$	4,000	$	(5,942)
Denominator (in thousands):
Denominator for basic EPS	31,673		31,492		31,622		31,469
Effect of dilutive employee stock options	61		40		52		—
Effect of convertible notes	9,201		9,085		—		—
Denominator for diluted EPS	40,935		40,617		31,674		31,469
Net earnings (loss) per share - basic:
Common Stock	$	0.43	$	0.29	$	0.13	$	(0.19)
Class B Common Stock	$	0.39	$	0.26	$	0.12	$	(0.18)
Net earnings (loss) per share - diluted:
Common Stock	$	0.35	$	0.24	$	0.13	$	(0.19)
Class B Common Stock	$	0.34	$	0.23	$	0.12	$	(0.18)

For the periods when the Company reports a net loss, common stock equivalents are excluded from the computation of diluted loss per share as their inclusion would have an antidilutive effect. During the 26 weeks ended June 30, 2022, approximately 61,791 common stock equivalents were excluded from the computation of diluted loss per share due to the Company’s net loss. During the 26 weeks ended June 29, 2023, and June 30, 2022, respectively, 9,200,907 and 9,084,924 shares related to the convertible notes were excluded from the computation of diluted loss per share as the effect would have been anti-dilutive.

Shareholders’ Equity - Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 13 and 26 weeks ended June 29, 2023 and June 30, 2022 was as follows:


	Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 29, 2022	$	24,498	$	7,111	$	153,794	$	274,254	$	(1,694)	$	(1,866)	$	456,097	$	824	$	456,921
Cash dividends:
$0.045 per share Class B Common Stock	—		—		—		(319)		—		—		(319)		—		(319)
$0.05 per share Common Stock	—		—		—		(1,229)		—		—		(1,229)		—		(1,229)
Exercise of stock options	—		—		(1)		—		—		3		2		—		2
Purchase of treasury stock	—		—		—		—		—		(313)		(313)		—		(313)
Savings and profit-sharing contribution	79		—		1,180		—		—		—		1,259		—		1,259
Reissuance of treasury stock	—		—		(3)		—		—		24		21		—		21
Issuance of non-vested stock	82		—		(143)		—		—		61		—		—		—
Shared-based compensation	—		—		2,172		—		—		—		2,172		—		2,172
Other	—		—		1		(1)		—		—		—		—		—
Conversions of Class B Common Stock	33		(33)		—		—		—		—		—		—		—
Distribution to noncontrolling interest	—		—		—		—		—		—		—		(550)		(550)
Comprehensive loss	—		—		—		(9,466)		(91)		—		(9,557)		—		(9,557)
BALANCES AT MARCH 30, 2023	$	24,692	$	7,078	$	157,000	$	263,239	$	(1,785)	$	(2,091)	$	448,133	$	274	$	448,407
Cash dividends:
$0.045 per share Class B Common Stock	—		—		—		(319)		—		—		(319)		—		(319)
$0.05 per share Common Stock	—		—		—		(1,230)		—		—		(1,230)		—		(1,230)
Exercise of stock options	—		—		(25)		—		—		121		96		—		96
Purchase of treasury stock	—		—		—		—		—		(226)		(226)		—		(226)
Reissuance of treasury stock	—		—		(204)		—		—		223		19		—		19
Issuance of non-vested stock	—		—		(55)		—		—		55		—		—		—
Shared-based compensation	—		—		1,515		—		—		—		1,515		—		1,515
Other	—		—		—		1		—		(1)		—		—		—
Distribution to noncontrolling interest	—		—		—		—		—		—		—		(274)		(274)
Comprehensive income (loss)	—		—		—		13,466		(12)		—		13,454		—		13,454
BALANCES AT JUNE 29, 2023	$	24,692	$	7,078	$	158,231	$	275,157	$	(1,797)	$	(1,919)	$	461,442	$	—	$	461,442


	Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 30, 2021	$	24,345	$	7,130	$	145,656	$	289,306	$	(11,444)	$	(1,379)	$	453,614	$	—	$	453,614
Exercise of stock options	—		—		(5)		—		—		31		26		—		26
Purchase of treasury stock	—		—		—		—		—		(1,373)		(1,373)		—		(1,373)
Savings and profit-sharing contribution	56		—		900		—		—		—		956		—		956
Reissuance of treasury stock	—		—		1		—		—		8		9		—		9
Issuance of non-vested stock	78		—		(236)		—		—		158		—		—		—
Shared-based compensation	—		—		2,917		—		—		—		2,917		—		2,917
Other	—		—		1		(1)		—		—		—		—		—
Conversions of Class B Common Stock	19		(19)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(14,902)		531		—		(14,371)		—		(14,371)
BALANCES AT MARCH 31, 2022	$	24,498	$	7,111	$	149,234	$	274,403	$	(10,913)	$	(2,555)	$	441,778	$	—	$	441,778
Exercise of stock options	—		—		(16)		—		—		69		53		—		53
Purchase of treasury stock	—		—		—		—		—		(104)		(104)		—		(104)
Reissuance of treasury stock	—		—		(2)		—		—		9		7		—		7
Issuance of non-vested stock	—		—		(305)		—		—		305		—		—		—
Shared-based compensation	—		—		1,655		—		—		—		1,655		—		1,655

Comprehensive income	—		—		—		8,960		384		—		9,344		—		9,344
BALANCES AT JUNE 30, 2022	$	24,498	$	7,111	$	150,565	$	283,364	$	(10,529)	$	(2,276)	$	452,733	$	—	$	452,733

Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:


	June 29, 2023		December 29, 2022

Unrecognized gain on interest rate swap agreements	$	—	$	80
Net unrecognized actuarial loss for pension obligation	(1,797)		$	(1,774)
	$	(1,797)	$	(1,694)

Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.

The Company’s assets and liabilities measured at fair value are classified in one of the following categories:

Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At June 29, 2023 and December 29, 2022, respectively, the Company’s $4,894 and $3,932 of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At June 29, 2023 and December 29, 2022, respectively, the Company’s $34,999 and $6,000 of investments in money market funds were valued using Level 1 pricing inputs and were included in cash and cash equivalents.

Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At December 29, 2022, the Company’s $108 asset related to the Company’s interest rate swap contract was valued using Level 2 pricing inputs. This contracted terminated on March 1, 2023.

Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At June 29, 2023 and December 29, 2022, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs.

The carrying value of the Company’s financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company’s $80,000 of senior notes, valued using Level 2 pricing inputs, is approximately $72,187 at June 29, 2023, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The fair value of the Company's $100,050 of convertible senior notes, valued using Level 2 pricing inputs, is approximately $150,020 at June 29, 2023, determined based on market rates and the closing trading price of the convertible senior notes as of June 29, 2023. The carrying amounts of the Company’s remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs.

Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:


	13 Weeks Ended				26 Weeks Ended
	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Service cost	$	122	$	264	$	244	$	528
Interest cost	452		335		905		670
Net amortization of prior service cost and actuarial loss	(16)		257		(32)		514
Net periodic pension cost	$	558	$	856	$	1,117	$	1,712

Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings.

Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 26 weeks ended June 29, 2023 is as follows:


	13 Weeks Ended June 29, 2023
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	68,987	$	—	$	—	$	68,987
Rooms	—		28,646		—		28,646
Theatre concessions	59,707		—		—		59,707
Food and beverage	—		18,573		—		18,573
Other revenues(1)	8,156		13,181		91		21,428
Cost reimbursements	—		9,666		—		9,666
Total revenues	$	136,850	$	70,066	$	91	$	207,007


	26 Weeks Ended June 29, 2023
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	116,622	$	—	$	—	$	116,622
Rooms	—		46,503		—		$	46,503
Theatre concessions	102,082		—		—		$	102,082
Food and beverage	—		33,766		—		$	33,766
Other revenues(1)	14,522		26,414		180		$	41,116
Cost reimbursements	—		19,194		—		$	19,194
Total revenues	$	233,226	$	125,877	$	180	$	359,283

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The disaggregation of revenues by business segment for the 13 and 26 weeks ended June 30, 2022 is as follows:


	13 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	63,087	$	—	$	—	$	63,087
Rooms	—		28,865		—		28,865
Theatre concessions	58,147		—		—		58,147
Food and beverage	—		19,014		—		19,014
Other revenues(1)	8,203		12,872		117		21,192
Cost reimbursements	—		8,250		—		8,250
Total revenues	$	129,437	$	69,001	$	117	$	198,555


	26 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	101,504	$	—	$	—	$	101,504
Rooms	—		46,295		—		46,295
Theatre concessions	93,611		—		—		93,611
Food and beverage	—		33,525		—		33,525
Other revenues(1)	13,813		25,975		211		39,999
Cost reimbursements	—		15,863		—		15,863
Total revenues	$	208,928	$	121,658	$	211	$	330,797

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The Company had deferred revenue from contracts with customers of $37,670 and $37,046 as of June 29, 2023 and December 29, 2022, respectively. The Company had no contract assets as of June 29, 2023 and December 29, 2022. During the 26 weeks ended June 29, 2023, the Company recognized revenue of $10,875 that was included in deferred revenues as of December 29, 2022. During the 26 weeks ended June 30, 2022, the Company recognized revenue of $9,448 that was included in deferred revenues as of December 30, 2021. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.

As of June 29, 2023, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $1,980 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of June 29, 2023, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $16,318 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the next two years.

As of June 29, 2023, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $3,834 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.

The majority of the Company’s revenue is recognized in less than one year from the original contract.

2. Long-Term Debt

Long-term debt is summarized as follows:


	June 29, 2023		December 29, 2022


Senior notes	$	80,000	$	80,000
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%	744		954
Convertible senior notes	100,050		100,050
Payroll Protection Program loans	1,687		2,240
Revolving credit agreement	—		—
Debt issuance costs	(2,306)		(2,807)
Total debt, net of debt issuance costs	180,175		180,437
Less current maturities, net of issuance costs	10,391		10,432
Long-term debt	$	169,784	$	170,005

Credit Agreement

On January 9, 2020, the Company replaced its then-existing credit agreement with several banks. On April 29, 2020, the Company entered into the First Amendment, on September 15, 2020, the Company entered into the Second Amendment, on July 13, 2021, the Company entered into the Third Amendment, on July 29, 2022, the Company entered into the Fourth Amendment and on February 10, 2023, the Company entered into the Fifth Amendment (the Credit Agreement, as amended by the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment and the Fifth Amendment, hereinafter referred to as the “Credit Agreement”).

The Credit Agreement provides for a revolving credit facility that matures on January 9, 2025 with an initial maximum aggregate amount of availability of $225,000. At June 29, 2023, there were borrowings of $0 outstanding on the revolving credit facility, which when borrowed, bear interest at the secured overnight financing rate (“SOFR”) plus a margin, effectively 6.22% at June 29, 2023. Availability under the line at June 29, 2023, was $220,623, after taking into consideration outstanding letters of credit that reduce revolver availability.

Effective with the Fifth Amendment on February 10, 2023, the variable rate LIBOR benchmark in the Credit Agreement was replaced with SOFR. Borrowings under the Credit Agreement now generally bear interest at a variable rate equal to: (i) SOFR plus a credit spread adjustment of 0.10%, subject to a 0% floor, plus a specified margin based upon our consolidated debt to capitalization ratio as of the most recent determination date; or (ii) the base rate (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1%

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and per share data)

plus one-month SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon our consolidated debt to capitalization ratio as of the most recent determination date. In addition, the Credit Agreement generally requires the Company to pay a facility fee equal to 0.125% to 0.25% of the total revolving commitment, depending on our consolidated debt to capitalization ratio, as defined in the Credit Agreement.

The Credit Agreement contains various restrictions and covenants. Among other requirements, the Credit Agreement (a) limits the amount of priority debt (as defined in the Credit Agreement) held by the Company’s restricted subsidiaries to no more than 20% of the Company’s consolidated total capitalization (as defined in the Credit Agreement), (b) limits the Company’s permissible consolidated debt to capitalization ratio to a maximum of 0.55 to 1.0, (c) requires the Company to maintain a consolidated fixed charge coverage ratio of at least 2.5 to 1.0 as of the end of the fiscal quarter ending March 30, 2023 and each fiscal quarter thereafter, and (d) restricts the Company’s ability to incur additional indebtedness and make voluntary prepayments on or defeasance of the Company’s 4.02% Senior Notes due August 2025, 4.32% Senior Notes due February 2027, the notes or certain other convertible securities. Beginning with the first quarter of fiscal 2023, the Company has returned to compliance with prior financial covenants under the Credit Agreement that were temporarily waived (specifically, the consolidated fixed charge coverage ratio), removing any limitations on the total amount of quarterly dividends or share repurchases. During fiscal 2022 the Credit Agreement limited the total amount of quarterly dividend payments or share repurchases to no more than $1,550 per quarter.

In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company’s subsidiaries have guaranteed the Company’s obligations under the Credit Agreement. The foregoing security interests, liens and guaranties will remain in effect until the Collateral Release Date (as defined in the Credit Agreement).

The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.

Note Purchase Agreements

At June 29, 2023 and December 29, 2022, the Company’s $80,000 of senior notes consist of two Purchase Agreements maturing in 2025 through 2027, require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.02% to 4.32%.

Convertible Senior Notes

On September 17, 2020, the Company entered into a purchase agreement to issue and sell $100,050 aggregate principal amount of its 5.00% Convertible Senior Notes due 2025 (the “Convertible Notes.”) The Convertible Notes were issued pursuant to an indenture (the “Indenture”), dated September 22, 2020, between the Company and U.S. Bank National Association, as trustee.

The Convertible Notes bear interest from September 22, 2020 at a rate of 5.00% per year. Interest will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Convertible Notes may bear additional interest under specified circumstances relating to the Company’s failure to comply with its reporting obligations under the Indenture or if the Convertible Notes are not freely tradeable as required by the Indenture. The Convertible Notes will mature on September 15, 2025, unless earlier repurchased or converted. Prior to March 15, 2025, the Convertible Notes will be convertible at the option of the holders only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ending on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period immediately after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and per share data)

product of the last reported sale price of the Common Stock and the conversion rate on each such trading day; or (iii) upon the occurrence of specified corporate events. On or after March 15, 2025, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.

Upon conversion, the Convertible Notes may be settled, at the Company’s election, in cash, shares of Common Stock or a combination thereof. The initial conversion rate was 90.8038 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $11.01 per share of Common Stock), representing an initial conversion premium of approximately 22.5% to the $8.99 last reported sale price of the Common Stock on The New York Stock Exchange on September 17, 2020. The conversion rate is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At June 29, 2023, the applicable conversion rate is 91.9631 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an applicable conversion price of approximately $10.87 per share of Common Stock). If the Company undergoes certain fundamental changes, holders of Convertible Notes may require the Company to repurchase for cash all or part of their Convertible Notes for a purchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a make-whole fundamental change occurs prior to the maturity date, the Company will, under certain circumstances, increase the conversion rate for holders who convert Convertible Notes in connection with such make-whole fundamental change. The Company may not redeem the Convertible Notes before maturity and no “sinking fund” is provided for the Convertible Notes. The Indenture includes covenants customary for securities similar to the Convertible Notes, sets forth certain events of default after which the Convertible Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company and certain of its subsidiaries after which the Convertible Notes become automatically due and payable.

Since the Company’s fiscal 2021 second quarter through the Company’s fiscal 2023 third quarter, the Company’s Convertible Notes were (are) eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. The Company has the ability to settle the conversion in Company stock. As such, the Convertible Notes will continue to be classified as long-term. Future convertibility and resulting balance sheet classification of this liability will be monitored at each quarterly reporting date and will be analyzed dependent upon market prices of the Company’s Common Stock during the prescribed measurement period. No Convertible Notes have been converted to date and the Company does not expect any to be converted within the next 12 months.

In connection with the pricing of the Convertible Notes on September 17, 2020, and in connection with the exercise by the Initial Purchasers (as defined in the Convertible Notes purchase agreement) of their option to purchase additional Convertible Notes on September 18, 2020, the Company entered into privately negotiated Capped Call Transactions (the “Capped Call Transactions”) with certain of the Initial Purchasers and/or their respective affiliates and/or other financial institutions (the “Capped Call Counterparties”). The Capped Call Transactions are expected generally to reduce potential dilution of the Company’s common stock upon any conversion of the Convertible Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of such converted Convertible Notes, as the case may be, in the event that the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which initially corresponds to the conversion price of the Convertible Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, there would nevertheless be dilution to the extent that such market price exceeds the cap price of the Capped Call Transactions. The cap price of the Capped Call Transactions was initially $17.98 per share (in no event shall the cap price be less than the strike price of $11.0128), which represents a premium of 100% over the last reported sale price of the Common Stock of $8.99 per share on The New York Stock Exchange on September 17, 2020. Under the terms of the Capped Call Transactions, the cap price is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At June 29, 2023, the adjusted cap price is approximately $17.75 per share. The Capped Call Transactions are separate transactions entered into by the Company with the Capped Call Counterparties, are not part

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and per share data)

of the terms of the Convertible Notes and will not change the rights of holders of the Convertible Notes under the Convertible Notes and the Indenture.

3. Leases

The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to accounting guidance ASU No. 2016-02, Leases (Topic 842). The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.

The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.

Total lease cost consists of the following:


		13 Weeks Ended				26 Weeks Ended
Lease Cost	Classification	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Finance lease costs:
Amortization of finance lease assets	Depreciation and amortization	$	688	$	696	$	1,379	$	1,401
Interest on lease liabilities	Interest expense	192		216		390		437
		$	880	$	912	$	1,769	$	1,838
Operating lease costs:
Operating lease costs	Rent expense	$	6,033	$	6,364	$	12,077	$	12,741
Variable lease cost	Rent expense	527		178		943		15
Short-term lease cost	Rent expense	34		36		67		72
		$	6,594	$	6,578	$	13,087	$	12,828

Additional information related to leases is as follows:


	13 Weeks Ended				26 Weeks Ended
Other Information	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases	$	645	$	752	$	1,201	$	1,336
Operating cash flows from finance leases	192		216		390		437
Operating cash flows from operating leases	6,429		7,012		12,859		$	14,136

Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities	136		116		136		188
Operating lease liabilities	—		—		—		183

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and per share data)


	June 29, 2023		December 29, 2022

Finance leases:
Property and equipment – gross	$	29,997	$	29,885
Accumulated depreciation and amortization	(16,687)		(15,332)
Property and equipment - net	$	13,310	$	14,553

Remaining lease terms and discount rates are as follows:

Lease Term and Discount Rate

June 29, 2023

December 29, 2022

Weighted-average remaining lease terms:

Finance leases

7 years

Operating leases

12 years

Weighted-average discount rates:

Finance leases

4.59

Operating leases

4.51

Deferred rent payments of approximately $753 for the Company’s operating leases have been included in the total operating lease obligations as of June 29, 2023, of which approximately $550 is included in long-term operating lease obligations.

4. Income Taxes

The Company’s effective income tax rate for the 13 and 26 weeks ended June 29, 2023 was 23.3% and 24.0%, respectively, and was 34.7% and 23.1% for the 13 and 26 weeks ended June 30, 2022, respectively. The effective tax rate for the 13 weeks ended June 30, 2022 includes discrete tax expense related to various matters. During the 26 weeks ended June 30, 2022, the Company received $22,959 of income tax refunds related to its fiscal 2020 tax return, including $636 of interest which is included within income tax benefit in the consolidated statement of earnings (loss).

5. Business Segment Information

The Company’s primary operations are reported in the following business segments: Theatres and Hotels/Resorts. Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues.

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and per share data)

Following is a summary of business segment information for the 13 and 26 weeks ended June 29, 2023 and June 30, 2022:


13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 29, 2023
Revenues	$	136,850	$	70,066	$	91	$	207,007
Operating income (loss)	19,811		6,105		(5,106)		20,810
Depreciation and amortization	11,317		4,588		89		15,994

13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	129,437	$	69,001	$	117	$	198,555
Operating income (loss)	16,430		6,817		(4,354)		18,893
Depreciation and amortization	11,863		4,801		88		16,752


26 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 29, 2023
Revenues	$	233,226	$	125,877	$	180	$	359,283
Operating income (loss)	21,330		1,073		(10,581)		11,822
Depreciation and amortization	22,805		8,889		176		31,870

26 weeks ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	208,928	$	121,658	$	211	$	330,797
Operating income (loss)	8,410		3,843		(10,157)		2,096
Depreciation and amortization	24,054		9,751		178		33,983

Table of Contents

THE MARCUS CORPORATION

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

Certain matters discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) and elsewhere in this Form 10-Q are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects the COVID-19 pandemic, or future pandemics, may have on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division (including disruptions in the production of films due to events such as a strike by actors, writers or directors); (3) the effects of theatre industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets; (5) the effects of adverse economic conditions on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (12) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (13) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in the United States, other incidents of violence in public venues such as hotels and movie theatres or epidemics; and (14) a disruption in our business and reputational and economic risks associated with civil securities claims brought by shareholders. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Our forward-looking statements are based upon our assumptions, which are based upon currently available information. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

RESULTS OF OPERATIONS

General

We report our consolidated and individual segment results of operations on a 52- or 53-week fiscal year ending on the last Thursday in December. Fiscal 2023 is a 52-week year beginning on December 30, 2022 and ending on December 28, 2023. Fiscal 2022 was a 52-week year that began on December 31, 2021 and ended on December 29, 2022.

We divide our fiscal year into three 13-week quarters and a final quarter consisting of 13 or 14 weeks. The second quarter of fiscal 2023 consisted of the 13-week period beginning on March 31, 2023 and ended on June 29, 2023. The second quarter of fiscal 2022 consisted of the 13-week period beginning April 1, 2022 and ended on June 30, 2022. The first half of fiscal 2023 consisted of the 26-week period beginning on December 30, 2022 and ended on June 29, 2023. The first half of fiscal 2022 consisted of the 26-week period beginning December 31, 2021 and ended on June 30, 2022. Our primary operations are reported in the following two business segments: movie theatres and hotels and resorts. Within this MD&A, amounts for totals, subtotals, and variances may not recalculate exactly within tables due to rounding as they are calculated using the unrounded numbers.

Table of Contents

COVID-19 did not materially impact our results for the first quarter and first half of fiscal 2023. For discussion regarding the impact of COVID-19 and related economic conditions on our results for the year ended December 29, 2022, see “Part II-Item 7-Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2022 Annual Report. For discussion regarding potential impacts of future pandemics refer to the discussion of our operational risks and financial risks found in “Part I-Item 1A-Risk Factors” in our 2022 Annual Report.

Overall Results

The following table sets forth revenues, operating income, other income (expense), net earnings (loss) and net earnings (loss) per diluted common share for the second quarter and first half of fiscal 2023 and fiscal 2022 (in millions, except for per share and variance percentage data):


	Second Quarter								First Half
					Variance								Variance
	F2023		F2022		Amt.		Pct.		F2023		F2022		Amt.		Pct.
Revenues	$	207.0	$	198.6	$	8.5	4.3	%	$	359.3	$	330.8	$	28.5	8.6	%
Operating income	20.8		18.9		1.9		10.1	%	11.8		2.1		9.7		464.0	%
Other income (expense)	(3.2)		(5.2)		1.9		37.3	%	(6.6)		(9.8)		3.3		33.2	%
Net earnings (loss)	$	13.5	$	9.0	$	4.5	50.3	%	$	4.0	$	(5.9)	$	9.9	167.3	%
Net earnings (loss) per common share - diluted	$	0.35	$	0.24	$	0.11	45.8	%	$	0.13	$	(0.19)	$	0.32	168.4	%

Revenues increased and operating income, net earnings (loss) and net earnings (loss) per diluted common share improved during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022. Increased revenues and operating income from both our theatre division and hotels and resorts division contributed to the improvement during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022. The first half of fiscal 2022 was negatively impacted due to the fact that releases of new films were limited and travel was reduced due to the lingering impacts of the COVID-19 pandemic and subsequent variants, particularly during the first quarter of fiscal 2022.

Net earnings (loss) during the second quarter and first half of fiscal 2023 was favorably impacted by decreased interest expense compared to the second quarter and first half of fiscal 2022 and investment income during the second quarter and first half of fiscal 2023 compared to investment losses in the second quarter and first half of fiscal 2022.

We recognized investment income of $0.4 million and $0.6 million during the second quarter and first half of fiscal 2023, respectively, compared to investment losses of $0.5 million and $0.7 million for the respective fiscal 2022 periods. Variations in investment income were due to changes in the value of marketable securities.

Our interest expense totaled $3.1 million and $6.1 million for the second quarter and first half of fiscal 2023, respectively, compared to $4.1 million and $8.2 million for the respective fiscal 2022 periods. The decrease in interest expense in fiscal 2023 was primarily due to decreased borrowings and a decrease in non-cash amortization of deferred financing costs. Changes in our borrowing levels due to variations in our operating results, capital expenditures, acquisition opportunities (or the lack thereof) and asset sale proceeds, among other items, may impact, either favorably or unfavorably, our actual reported interest expense in future periods, as may changes in short-term interest rates.

We reported income tax expense for the second quarter of fiscal 2023 of $4.1 million compared to income tax expense of $4.8 million during the second quarter of fiscal 2022. We reported income tax expense for the first half of fiscal 2023 of $1.3 million compared to an income tax benefit of $1.8 million during the first half of fiscal 2022. Our fiscal 2023 first half effective income tax rate was 24.0%. Our fiscal 2022 first half effective income tax rate was 23.1%. We anticipate that our effective income tax rate for fiscal 2023 may be in the 24-28% range, excluding any potential changes in federal or state income tax rates, valuation allowance adjustments or other one-time tax benefits. Our actual fiscal 2023 effective income tax rate may be different from our estimated quarterly rates depending upon actual facts and circumstances.

Table of Contents

Theatres

The following table sets forth revenues, operating income and operating margin for our theatre division for the second quarter and first half of fiscal 2023 and fiscal 2022 (in millions, except for variance percentage and operating margin):


	Second Quarter										First Half
							Variance										Variance
	F2023			F2022			Amt.		Pct.		F2023			F2022			Amt.		Pct.
Revenues	$	136.9		$	129.4		$	7.4	5.7	%	$	233.2		$	208.9		$	24.3	11.6	%
Operating income	19.8			16.4			3.4		20.6	%	21.3			8.4			12.9		153.6	%
Operating margin (% of revenues)	14.5		%	12.7		%					9.1		%	4.0		%

Our theatre division revenues and operating income increased during the second quarter and first half of fiscal 2023, with an increase in the number of new films released by movie studios resulting in higher attendance compared to the first half of fiscal 2022. Our operating income during the second quarter and first half of fiscal 2023 significantly improved compared to the second quarter and first half of fiscal 2022 as a result of higher overall revenues and greater labor productivity.

The following table provides a further breakdown of the components of revenues for the theatre division for the second quarter and first half of fiscal 2023 and fiscal 2022 (in millions, except for variance percentage):


	Second Quarter								First Half
					Variance								Variance
	F2023		F2022		Amt.		Pct.		F2023		F2022		Amt.		Pct.
Admission revenues	$	69.0	$	63.1	$	5.9	9.4	%	$	116.6	$	101.5	$	15.1	14.9	%
Concession revenues	59.7		58.1		1.6		2.7	%	102.1		93.6		8.5		9.0	%
Other revenues	8.2		8.2		—		(0.6)	%	14.5		13.8		0.7		5.1	%
Total revenues	136.9		129.4		7.4		5.7	%	233.2		208.9		24.3		11.6	%

According to data received from Comscore (a national box office reporting service for the theatre industry) and compiled by us to evaluate our fiscal 2023 second quarter and first half results, U.S. box office receipts increased 13.6% during our fiscal 2023 second quarter and 18.3% during our fiscal 2023 first half compared to the same comparable weeks in fiscal 2022, indicating that our increase in admission revenues for comparable theatres (excluding theatres closed during the past year) during the second quarter and first half of fiscal 2023 of 9.7% and 15.2% underperformed the industry by 3.9 and 3.1 percentage points, respectively. We believe our underperformance is attributable to the more significant impact of lingering variants of COVID-19 in other regions of the country than in our primarily Midwestern markets during the first half of fiscal 2022, representing a higher opportunity for growth in 2023 nationally than in our markets. We also believe our underperformance during the second quarter of fiscal 2023 is attributable to an unfavorable film mix that was more appealing to audiences in other parts of the U.S. outside of our Midwestern markets, as well as a dry May and June with few rainy days in the Midwest, resulting in customers preferring to enjoy early summer weather and outdoor activities over going to the movies.

Additional data received and compiled by us from Comscore indicates our admission revenues during the second quarter and first half of fiscal 2023 represented approximately 3.1% and 3.2%, respectively, of the total admission revenues in the U.S. during the periods (commonly referred to as market share in our industry). This represents a decrease over our market share for comparable theatres of approximately 3.2% and 3.3% during the second quarter and first half of fiscal 2022, respectively, which we believe is also attributable to lingering COVID-19 variants more significantly impacting other regions of the country during the comparable periods in fiscal 2022. Our reported market share during the comparable fiscal 2019 periods prior to the pandemic, was approximately 3.1%. Our goal is to continue our past long-term pattern of outperforming the industry, but our ability to do so in any given quarter will likely be partially dependent upon film mix, weather and the competitive landscape in our markets.

Total theatre attendance for our comparable theatres decreased 3.8% during the second quarter of fiscal 2023 compared to the second quarter of fiscal 2022, which was primarily attributable to lower performances from the top three films this year versus the top three films last year during the second quarter (led by Top Gun: Maverick), partially offset by the favorable

Table of Contents

impact of an increase in the number of wide-release films (films showed in over approximately 1,500 theatres in the U.S.). During the second quarter of fiscal 2023 there were 29 wide-release films compared to 19 wide-release films during the second quarter of fiscal 2022.

Total theatre attendance for our comparable theatres increased 3.0% during the first half of fiscal 2023 compared to the prior year period, resulting primarily from an increase in the number of wide-release films. During the first half of fiscal 2023 there were 52 wide-release films compared to 38 wide-release films during the first half of fiscal 2022.

Our highest grossing films during the fiscal 2023 second quarter included The Super Mario Bros. Movie, Guardians of the Galaxy Vol. 3, Spider-Man Across the Spider-Verse, The Little Mermaid and Fast X. Our top five films during our fiscal 2023 second quarter accounted for 64% of our total box office results, compared to 68% for the top five films during the second quarter of fiscal 2022, both expressed as a percentage of the total admission revenues for the period. A decreased concentration of blockbuster films during a given quarter often has the effect of lowering our film rental costs during the period, as generally the better a particular film performs, the greater the film rental cost tends to be as a percentage of box office receipts. While the second quarter of fiscal 2023 was slightly less concentrated on blockbuster films compared to the second quarter of fiscal 2022, our overall film rental cost as a percentage of admission revenues remained flat compared to the prior year.

Our average ticket price increased 14.2% and 12.0% during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, respectively, and was favorably impacted by inflationary price increases that we implemented in the second quarter of fiscal 2022 and in the first quarter of fiscal 2023 in response to increases in labor and supply costs, and by a higher percentage of 3D ticket sales. During the last week of the first quarter of fiscal 2023, we implemented several pricing changes to our Value Tuesday promotion across our theatre circuit, which has historically offered $5 admission and free complementary-size popcorn to our loyalty program members. Our new Value Tuesday promotion features $6 admission for members of our free Magical Movie Rewards (MMR) loyalty program and $7 admission for non-MMR customers. The overall increase in average ticket price favorably impacted our admission revenues of our comparable theatres by $8.5 million and $12.4 million during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, respectively.

Our average concession revenues per person increased by 7.3% and 6.3% during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, respectively, due to inflationary increases in concessions prices in response to increases in food and labor costs and due to the net positive impact of changes to our Value Tuesday promotion, which replaced free complementary-size popcorn with a 20% discount on all concessions, food and non-alcoholic beverages for MMR members. We also believe average concession revenues per person was positively impacted by a new food and beverage menu introduced in the fourth quarter of fiscal 2022. Finally, we believe that an increased percentage of customers buying their concessions in advance using our website, kiosk or our mobile app likely contributed to higher average concession revenues per person, as our experience has shown that customers are more likely to purchase more items when they order and pay electronically. The increase in average concession revenues per person favorably impacted our concession revenues of our comparable theatres by $3.9 million and $6.0 million during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, respectively.

Other revenues during the second quarter of fiscal 2023 were consistent with the second quarter of fiscal 2022. Other revenues increased by $0.7 million during the first half of fiscal 2023 compared to the first half of fiscal 2022. The increase was primarily due to the impact of increased attendance on internet surcharge ticketing fees and preshow and in-app advertising revenue.

Several films have performed well in the early weeks of our fiscal 2023 third quarter, including Indiana Jones & The Dial of Destiny, Mission: Impossible - Dead Reckoning Part One, Sound of Freedom, Barbie, and Oppenheimer. In fact, the last two films recently combined to produce the fourth highest box office weekend of all time. While the quantity of films available for theatrical exhibition remains below pre-pandemic levels, we expect to continue to see increases in the quantity of available films in 2023 compared to the prior year. Although it is possible that schedule changes may occur, new films scheduled to be released during the remainder of fiscal 2023 that have potential to perform very well include Gran Turismo, Teenage Mutant Ninja Turtles: Mutant Mayhem, Blue Beetle, Strays, The Meg 2: The Trench, The Equalizer 3, The Nun II, The Expendables 4, Paw Patrol: The Mighty Movie, Killers of the Flower Moon, Dune: Part Two, Trolls Band Together, Hunger Games: The Ballad of Songbirds and Snakes, Wish, Napoleon, Wonka, The Color Purple and Aquaman and the Lost Kingdom.

Table of Contents

Revenues for the theatre business and the motion picture industry in general are heavily dependent on the number of films produced by studios and the general audience appeal of available films, together with studio marketing, advertising and support campaigns and the maintenance of appropriate “windows” between the date a film is released in theatres and the date a motion picture is released to other channels, including premium video-on-demand (“PVOD”), video on-demand (“VOD”), streaming services and DVD. These are factors over which we have no control.

The quantity of films released to theatres is also dependent upon the timing of film production by the studios. On May 2, 2023, the union representing script writers, the Writers Guild of America (WGA), went on strike after its contract expired with the Alliance of Motion Picture and Television Producers (AMPTP), which represents media companies including film studios. On July 14, 2023, the union representing actors, the Screen Actors Guild - American Federation of Television and Radio Artists (SAG-AFTRA), also went on strike over an ongoing labor dispute with AMPTP. Film production has stopped as a result of these strikes, and a prolonged shutdown in film production may impact the film release schedule, particularly in 2024 and 2025.

We ended the second quarter of fiscal 2023 with a total of 1,027 company-owned screens in 82 theatres, compared to 1,064 company-owned screens in 85 theatres at the end of the second quarter of fiscal 2022. Early in our fiscal 2023 first quarter, we made the decision to close one of our owned theatres.

Hotels and Resorts

The following table sets forth revenues, operating income and operating margin for our hotels and resorts division for the second quarter and first half of fiscal 2023 and fiscal 2022 (in millions, except for variance percentage and operating margin):


	Second Quarter										First Half
							Variance										Variance
	F2023			F2022			Amt.		Pct.		F2023			F2022			Amt.		Pct.
Revenues	$	70.1		$	69.0		$	1.1	1.5	%	$	125.9		$	121.7		$	4.2	3.5	%
Operating income	6.1			6.8			(0.7)		(10.4)	%	1.1			3.8			(2.8)		(72.1)	%
Operating margin (% of revenues)	8.7		%	9.9		%					0.9		%	3.2		%

On December 16, 2022, we completed the sale of The Skirvin Hilton in Oklahoma City, Oklahoma (we held a majority-ownership position in this hotel prior to its sale). The results of The Skirvin Hilton are included in our divisional and consolidated results of operations during fiscal 2022 through the date of the sale.

Excluding The Skirvin Hilton from fiscal 2022 results, hotels and resorts revenues increased 8.5% and 10.7% during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, respectively. Our hotels and resorts division operating income during the second quarter and first half of fiscal 2023 decreased compared to the second quarter and first half of fiscal 2022 due to the sale of The Skirvin Hilton (which had operating income during the first quarter and first half of fiscal 2022) and increased labor costs during the fiscal 2023 periods as we increased our staffing levels to enhance the customer experience compared to the second quarter and first half of fiscal 2022 when various positions were unfilled due to staffing shortages.

Table of Contents

The following table provides a further breakdown of the components of revenues for the hotels and resorts division for the second quarter and first half of fiscal 2023 and fiscal 2022 (in millions, except for variance percentage):


	Second Quarter								First Half
					Variance								Variance
	F2023		F2022		Amt.		Pct.		F2023		F2022		Amt.		Pct.
Room revenues	$	28.6	$	28.9	$	(0.2)	(0.8)	%	$	46.5	$	46.3	$	0.2	0.4	%
Food/beverage revenues	18.6		19.0		(0.4)		(2.3)	%	33.8		33.5		0.2		0.7	%
Other revenues	13.2		12.9		0.3		2.4	%	26.4		26.0		0.4		1.7	%
Total revenues before cost reimbursements	60.4		60.8		(0.4)		(0.6)	%	106.7		105.8		0.9		0.8	%
Cost reimbursements	9.7		8.3		1.4		17.2	%	19.2		15.9		3.3		21.0	%
Total revenues	$	70.1	$	69.0	$	1.1	1.5	%	$	125.9	$	121.7	$	4.2	3.5	%

Division total revenues before cost reimbursements decreased during the second quarter of fiscal 2023 compared to the second quarter of fiscal 2022, due to the negative impact of the sale of The Skirvin Hilton. Excluding The Skirvin Hilton from fiscal 2022 results, division revenues before cost reimbursements increased $4.1 million, or 7.2% during the second quarter of fiscal 2023 compared to the second quarter of fiscal 2022 due to increased occupancy at four of our seven owned hotels and increased average daily rate at six of our seven owned hotels. Division total revenues before cost reimbursements increased during the first half of fiscal 2023 compared to the first half of fiscal 2022, despite the negative impact of the sale of the Skirvin Hilton, due to increased occupancy at five of our seven owned hotels and increased average daily rate at all seven of our owned hotels. Excluding The Skirvin Hilton from fiscal 2022 results, division revenues before cost reimbursements increased $8.9 million, or 9.0% during the first half of fiscal 2023 compared to the first half of fiscal 2022.

The following table sets forth certain operating statistics for the second quarter and first half of fiscal 2023 and fiscal 2022, including our average occupancy percentage (number of occupied rooms as a percentage of available rooms), our average daily room rate, or ADR, and our total revenue per available room, or RevPAR, for company-owned properties:


	Second Quarter										First Half
							Variance										Variance
	F2023			F2022			Amt.		Pct.		F2023			F2022			Amt.		Pct.
Occupancy pct.	68.2		%	65.3		%	2.9 pts		4.5	%	59.5		%	55.7		%	3.8 pts		6.8	%
ADR	$	187.34		$	179.33		$	8.01	4.5	%	$	173.68		$	165.40		$	8.28	5.0	%
RevPAR	$	127.70		$	117.07		$	10.63	9.1	%	$	103.33		$	92.13		$	11.20	12.2	%

Note: These operating statistics represent averages of our seven distinct comparable company-owned hotels and resorts, branded and unbranded, in different geographic markets with a wide range of individual hotel performance. The statistics are not necessarily representative of any particular hotel or resort. The Skirvin Hilton is not included in the fiscal 2022 statistics.

RevPAR increased at all seven of our comparable company-owned properties during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022. Group demand continued to grow during the fiscal 2023 second quarter, with weekday and weekend growth increasing group as a percentage of our overall business mix. During the second quarter of fiscal 2023, our group business represented approximately 40% of our total rooms revenue, compared to approximately 38% during the second quarter of fiscal 2022. Non-group pricing remained strong in the majority of our markets during the second quarter of fiscal 2023, with leisure demand contributing to increased ADR.

According to data received from Smith Travel Research and compiled by us in order to evaluate our fiscal 2023 second quarter and first half results, comparable “upper upscale” hotels—hotels identified as our industry— throughout the United States experienced an increase in RevPAR of 4.8% during our fiscal 2023 second quarter compared to the same period during fiscal 2022, leading us to believe we outperformed the industry during the fiscal 2023 second quarter by approximately 4.3 percentage points. During the first half of fiscal 2023 compared to the first half of fiscal 2022, comparable “upper upscale” hotels experienced an increase in RevPAR of 14.4%, leading us to believe we underperformed the industry during the first half of fiscal 2023 by approximately 2.2 percentage points. We believe our underperformance during the first half of fiscal 2023 occurred because occupancy at our hotels recovered earlier in fiscal 2022, particularly in the first quarter of fiscal 2022, than the industry, which generally lagged our occupancy levels in fiscal 2022. This resulted

Table of Contents

in the industry growing occupancy at a faster rate than our owned hotels during the first half of fiscal 2023 compared to the prior year.

Data received from Smith Travel Research for our various “competitive sets”—hotels identified in our specific markets that we deem to be competitors to our hotels—indicates that these hotels experienced an increase in RevPAR of 10.1% during our second quarter, again compared to the same period in fiscal 2022. Therefore, we believe we underperformed our competitive sets during the second quarter of fiscal 2023 by approximately 1.0 percentage point. We believe our underperformance to our competitive sets during the second quarter of fiscal 2023 results primarily from a customer mix shift with an increase in the percentage of group business at lower daily rates and a decrease in the percentage of leisure customers at higher daily rates. During the first half of fiscal 2023 compared to the first half of fiscal 2022, hotels in our competitive sets experienced an increase in RevPAR of 14.7%, leading us to believe we underperformed our competitive sets during the first half of fiscal 2023 by approximately 2.5 percentage points. We believe our underperformance to our competitive sets during the first half of fiscal 2023 results primarily from the unfavorable customer mix shift during the second quarter of fiscal 2023 and because occupancy at our hotels recovered earlier in fiscal 2022, particularly in the first quarter of fiscal 2022, than our competitive sets, which generally lagged our occupancy levels in fiscal 2022. This resulted in our competitive sets growing occupancy at a faster rate than our owned hotels during the first half of fiscal 2023 compared to the prior year.

Looking to future periods, overall occupancy in the U.S. is expected to continue to slowly increase. In the near term, we expect leisure travel demand to normalize. Leisure travel in our markets has a seasonal component, peaking in the summer months and slowing down as children return to school and the weather turns colder. We are experiencing gradual increases in business travel as corporate training events, meetings, and conferences return and downtown offices reopen. As of the date of this report, our group room revenue bookings for fiscal 2023 - commonly referred to in the hotels and resorts industry as “group pace” - is running approximately 8% ahead of where we were at the same time last year. Group room revenue bookings for fiscal 2024 is running approximately 7% ahead of where we were at the same time in early fiscal 2022 for fiscal 2023. Banquet and catering revenue pace for fiscal 2023 and fiscal 2024 is similarly running ahead of where we were at this same time last year. We are encouraged by continuing positive trends in group bookings for fiscal 2023 and beyond.

Adjusted EBITDA

Adjusted EBITDA is a measure used by management and our board of directors to assess our financial performance and enterprise value. We believe that Adjusted EBITDA is a useful measure for us and investors, as it eliminates certain expenses that are not indicative of our core operating performance and facilitates a comparison of our core operating performance on a consistent basis from period to period. We also use Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.

Adjusted EBITDA is a non-GAAP measure of our financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. Adjusted EBITDA has its limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP.

We define Adjusted EBITDA as net earnings (loss) attributable to The Marcus Corporation before investment income or loss, interest expense, other expense, gain or loss on disposition of property, equipment and other assets, equity earnings or losses from unconsolidated joint ventures, net earnings or losses attributable to noncontrolling interests, income taxes, depreciation and amortization and non-cash share-based compensation expense, adjusted to eliminate the impact of certain items that we do not consider indicative of our core operating performance. These further adjustments are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by us may not be comparable to the measures disclosed by other companies.

Table of Contents

The following table sets forth Adjusted EBITDA by reportable operating segment for the second quarter and first half of fiscal 2023 and fiscal 2022 (in millions, except for variance percentage):


	Second Quarter								First Half
					Variance								Variance
	F2023		F2022		Amt.		Pct.		F2023		F2022		Amt.		Pct.
Theatres	$	31.3	$	28.8	$	2.5	8.7	%	$	45.1	$	33.5	$	11.5	34.4	%
Hotels and resorts	11.3		11.8		(0.5)		(4.2)	%	10.9		14.2		(3.3)		(23.2)	%
Corporate items	(3.9)		(3.3)		(0.6)		(18.4)	%	(7.8)		(7.1)		(0.7)		(10.2)	%
Total Adjusted EBITDA	$	38.7	$	37.3	$	1.4	3.7	%	$	48.2	$	40.7	$	7.5	18.5	%

The following table sets forth our reconciliation of Adjusted EBITDA (in millions):


	Second Quarter				First Half
	F2023		F2022		F2023		F2022
Net earnings (loss)	$	13.5	$	9.0	$	4.0	$	(5.9)
Add (deduct):
Investment (income) loss	(0.4)		0.5		(0.6)		0.7
Interest expense	3.1		4.1		6.1		8.2
Other (income) expense	0.5		0.6		0.9		1.2
Loss (gain) on disposition of property, equipment and other assets	0.4		0.1		0.8		(0.4)
Equity losses from unconsolidated joint ventures	—		—		0.2		0.1

Income tax expense (benefit)	4.1		4.8		1.3		(1.8)
Depreciation and amortization	16.0		16.8		31.9		34.0
Share-based compensation expenses (1)	1.5		1.7		3.7		4.6


Total Adjusted EBITDA	$	38.7	$	37.3	$	48.2	$	40.7

The following tables sets forth our reconciliation of Adjusted EBITDA by reportable operating segment (in millions):


	Second Quarter, F2023								First Half, F2023
	Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total
Operating income (loss)	$	19.8	$	6.1	$	(5.1)	$	20.8	$	21.3	$	1.1	$	(10.6)	11.8
Depreciation and amortization	11.3		4.6		0.1		16.0		22.8		8.9		0.2		31.9
Loss (gain) on disposition of property, equipment and other assets	—		0.4		—		0.4		0.3		0.5		—		0.8
Share-based compensation (1)	0.1		0.2		1.1		1.5		0.6		0.5		2.6		3.7


Total Adjusted EBITDA	$	31.3	$	11.3	$	(3.9)	$	38.7	$	45.1	$	10.9	(7.8)		48.2


	Second Quarter, F2022								First Half, F2022
	Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total
Operating loss	$	16.4	$	6.8	$	(4.4)	$	18.9	$	8.4	$	3.8	$	(10.2)	2.1
Depreciation and amortization	11.9		4.8		0.1		16.8		24.1		9.8		0.2		34.0
Share-based compensation (1)	0.5		0.2		1.0		1.7		1.1		0.6		2.9		4.6
Total Adjusted EBITDA	$	28.8	$	11.8	$	(3.3)	$	37.3	$	33.5	$	14.2	$	(7.1)	$	40.7

(1)Non-cash expense related to share-based compensation programs.

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

Our movie theatre and hotels and resorts businesses, when open and operating normally, each generate significant and consistent daily amounts of cash, subject to previously-noted seasonality, because each segment’s revenue is derived predominantly from consumer cash purchases. Under normal circumstances, we believe that these relatively consistent and predictable cash sources, as well as the availability of unused credit lines, would be adequate to support the ongoing operational liquidity needs of our businesses.

Maintaining and protecting a strong balance sheet has always been a core value of The Marcus Corporation during our 88-year history and our financial position remains strong. As of June 29, 2023, we had a cash balance of approximately $44.6 million, $220.6 million of availability under our $225 million revolving credit facility, and our debt-to-capitalization ratio was 0.28. With our strong liquidity position combined with cash generated from operations, we believe we are positioned to have sufficient liquidity to meet our obligations as they come due and to comply with our debt covenants for at least 12 months from the issuance date of the consolidated financial statements, as well as our longer-term capital requirements.

Financial Condition

Net cash provided by operating activities totaled $47.3 million during the first half of fiscal 2023, compared to net cash provided by operating activities of $55.2 million during the first half of fiscal 2022. The $7.9 million decrease in net cash provided by operating activities was due to the receipt of refundable income taxes of $22.7 million and government grants of $4.3 million during the first half of fiscal 2022 that did not recur in fiscal 2023, partially offset by an increase in net earnings and the favorable timing in the payment of accounts payable and other working capital payments during the first half of fiscal 2023 compared to the first half of fiscal 2022.

Net cash used in investing activities during the first half of fiscal 2023 totaled $16.6 million, compared to net cash used in investing activities of $11.5 million during the first half of fiscal 2022. The increase in net cash used in investing activities of $5.2 million was the result of the impact of the sale of non-core real estate assets of $4.8 million during the first half of fiscal 2022 that did not recur in fiscal 2023 and an increase in cash used in the purchase of trading securities and other investing activities, partially offset by a decrease of $0.4 million in capital expenditures. Total cash capital expenditures (including normal continuing capital maintenance and renovation projects) totaled $15.9 million during the first half of fiscal 2023 compared to $16.3 million during the first half of fiscal 2022.

Fiscal 2023 first half cash capital expenditures included approximately $6.8 million incurred in our theatre division, primarily related to normal maintenance capital projects. We also incurred capital expenditures in our hotels and resorts division during the first half of fiscal 2023 of approximately $8.9 million, including costs related to guest room renovations at the Grand Geneva Resort and Spa and normal maintenance capital projects.

Net cash used in financing activities during the first half of fiscal 2023 totaled $6.3 million compared to net cash used in financing activities of $4.4 million during the first half of fiscal 2022. During the first half of fiscal 2023, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As short-term revolving credit facility borrowings became due, we replaced them as necessary with new short-term revolving credit facility borrowings. As a result, we added $38.0 million of new short-term revolving credit facility borrowings, and we made $38.0 million of repayments on short-term revolving credit facility borrowings during the first half of fiscal 2023 (net zero borrowings on our credit facility). We ended the second quarter of fiscal 2023 with no outstanding borrowings under our revolving credit facility. During the first half of fiscal 2022, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As a result, we added $22.0 million of new short-term revolving credit facility borrowings, and we made $22.0 million of repayments on short-term revolving credit facility borrowings during the first half of fiscal 2022 (net zero borrowings on our credit facility).

Principal payments on long-term debt were approximately $0.8 million during the first half of fiscal 2023 compared to payments of $0.9 million during the first half of fiscal 2022. Our debt-to-capitalization ratio (excluding our finance and operating lease obligations) was 0.28 at June 29, 2023, compared to 0.28 at December 29, 2022.

During the first half of fiscal 2023 and the first half of fiscal 2022, we did not repurchase any shares of our common stock in the open market. As of June 29, 2023, approximately 2.5 million shares remained available for repurchase under prior

Table of Contents

Board of Directors repurchase authorizations. Under these authorizations, we may repurchase shares of our common stock from time to time in the open market, pursuant to privately-negotiated transactions or otherwise, depending upon a number of factors, including prevailing market conditions.

Dividends paid during the first half of fiscal 2023 were $3.1 million. We did not make any dividend payments during the first half of fiscal 2022. Our Credit Agreement, as amended, limited the total amount of quarterly dividend payments or share repurchases during fiscal 2022 to no more than $1.55 million per quarter. Beginning with the first quarter of fiscal 2023, we returned to compliance with prior financial covenants under the Credit Agreement that were temporarily waived (specifically, the consolidated fixed charge coverage ratio), removing any limitations on the total amount of quarterly dividends or share repurchases. We have the ability to declare quarterly dividend payments and/or repurchase shares of our common stock in the open market as we deem appropriate.

During the first quarter of fiscal 2023, we amended the Credit Agreement by entering into the Fifth Amendment effective on February 10, 2023, which replaced the variable rate LIBOR benchmark with the secured overnight financing rate (“SOFR”). Borrowings under the Credit Agreement now generally bear interest at a variable rate equal to: (i) SOFR plus a credit spread adjustment of 0.10%, subject to a 0% floor, plus a specified margin based upon our consolidated debt to capitalization ratio as of the most recent determination date; or (ii) the base rate (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon our consolidated debt to capitalization ratio as of the most recent determination date. In addition, the Credit Agreement generally requires us to pay a facility fee equal to 0.125% to 0.25% of the total revolving commitment, depending on our consolidated debt to capitalization ratio, as defined in the Credit Agreement.

Critical Accounting Policies and Estimates

We have included a summary of our Critical Accounting Policies and Estimates in our Annual Report on Form 10-K for the year ended December 29, 2022. There have been no material changes to the summary provided in that report.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We have not experienced any material changes in our market risk exposures since December 29, 2022.

Item 4. Controls and Procedures

a.Evaluation of disclosure controls and procedures

Based on their evaluations and the evaluation of management, as of the end of the period covered by this Quarterly Report on Form 10-Q, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

b.Changes in internal control over financial reporting

There were no significant changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15 of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 29, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth information with respect to purchases made by us or on our behalf of our Common Stock during the periods indicated.


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Programs (1)	Maximum Number of Shares that May Yet be Purchased Under the Plans or Programs (1)
March 31 - April 27	—	$	—	—	2,502,788
April 28 - June 1	13,877	15.96		13,877	2,488,911
June 2 - June 29	—	—		—	2,488,911
Total	13,877	$	15.74	13,877	2,488,911

(1)Through June 29, 2023, our Board of Directors had authorized the repurchase of up to approximately 11.7 million shares of our outstanding Common Stock. Under these authorizations, we may repurchase shares of our Common Stock from time to time in the open market, pursuant to privately negotiated transactions or otherwise. As of June 29, 2023, we had repurchased approximately 9.2 million shares of our Common Stock under these authorizations. The repurchased shares are held in our treasury pending potential future issuance in connection with employee benefit, option or stock ownership plans or other general corporate purposes. These authorizations do not have an expiration date. The shares purchased during the second quarter of 2022 were purchased in conjunction with the exercise of stock options pursuant to the publicly announced repurchase authorization.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

[During the thirteen weeks ended June 29, 2023, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.]

Table of Contents

Item 6. Exhibits



10.1			Employee Advisory Services Agreement, dated May 23, 2023, between the Company and Stephen H. Marcus. [Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K dated May 23, 2023.]


31.1			Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2			Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32			Written Statement of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350.

101.INS			The instance document does not appear in the interactive data file because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document.

101.SCH			Inline XBRL Taxonomy Extension Schema Document.

101.CAL			Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF			Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB			Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE			Inline XBRL Taxonomy Extension Presentation Linkbase Document

104			Cover Page Interactive Data File (embedded within the Inline XBRL document).

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


THE MARCUS CORPORATION

DATE: August 2, 2023	By:	/s/ Gregory S. Marcus
		Gregory S. Marcus
		President and Chief Executive Officer


DATE: August 2, 2023	By:	/s/ Chad M. Paris
		Chad M. Paris
		Chief Financial Officer and Treasurer

S-1

Marcus Corporation - 10-Q quarterly report FY2023 Q2

What is the market capitalization of a company?

DISCLAIMER

Contact

Links


		Page
PART I – FINANCIAL INFORMATION

Item 1.	Consolidated Financial Statements (Unaudited):

	Consolidated Balance Sheets	3

	Consolidated Statements of Earnings (Loss)	5

	Consolidated Statements of Comprehensive Income (Loss)	6

	Consolidated Statements of Cash Flows	7

	Condensed Notes to Consolidated Financial Statements	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	23

Item 4.	Controls and Procedures	23

PART II – OTHER INFORMATION

Item 1A.	Risk Factors	24

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	24

Item 4.	Mine Safety Disclosures	24

Item 6.	Exhibits	25

	Signatures	S-1